Clinical Trial Update: Study Evaluating Management of Patients With Community-Acquired Pneumonia (CAP) or Complicated Skin Infections

View source ↗

Summary

AstraZeneca-sponsored trial evaluating management of patients with community-acquired pneumonia and complicated skin and soft tissue infections has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Community-acquired Pneumonia
• Complicated Skin and Soft Tissue Infections

Snippet

Sponsor: AstraZeneca | Conditions: Community Acquired Pneumonia (CAP), Complicated Skin and Skin Structures Infections (cSSSI) | Status: COMPLETED